Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIGF-I pilot study in liver cirrhosis
NL-OMON37474Not yet recruiting
- Sponsor
- Stichting Leveronderzoek
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of mecasermin in Cirrhosis, sponsored by Stichting Leveronderzoek. Primary endpoint: Body composition. Planned start May 2012; status: not yet recruiting.
02
Drugs
mecasermin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NL-OMON37474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37474.